TABLE OF CONTENTS
Volume 16, Issue S1 (June 2004)
Top of page
Top of page
Editorial Commentary
Editorial Commentary FREE
Vincent Manganiello
Int J Impot Res 16: S1-S3; doi:10.1038/sj.ijir.3901206
Original Researches
Mechanisms of action of PDE5 inhibition in erectile dysfunction FREE
J D Corbin
Int J Impot Res 16: S4-S7; doi:10.1038/sj.ijir.3901205
Tissue expression, distribution, and regulation of PDE5 FREE
C-S Lin
Int J Impot Res 16: S8-S10; doi:10.1038/sj.ijir.3901207
Potency, selectivity, and consequences of nonselectivity of PDE inhibition FREE
E Bischoff
Int J Impot Res 16: S11-S14; doi:10.1038/sj.ijir.3901208
Novel nitric oxide signaling mechanisms regulate the erectile response FREE
A L Burnett
Int J Impot Res 16: S15-S19; doi:10.1038/sj.ijir.3901209
Cardiovascular implications in the use of PDE5 inhibitor therapy FREE
D H Maurice
Int J Impot Res 16: S20-S23; doi:10.1038/sj.ijir.3901210
Implications of PDE4 structure on inhibitor selectivity across PDE families FREE
H Ke
Int J Impot Res 16: S24-S27; doi:10.1038/sj.ijir.3901211
Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5 FREE
R H Cote
Int J Impot Res 16: S28-S33; doi:10.1038/sj.ijir.3901212
Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events FREE
E Bischoff
Int J Impot Res 16: S34-S37; doi:10.1038/sj.ijir.3901213
Growth factor therapy and neuronal nitric oxide synthase FREE
C-S Lin and T F Lue
Int J Impot Res 16: S38-S39; doi:10.1038/sj.ijir.3901214
